VISCHER advised EraCal on all legal issues related to the transaction. EraCal Therapeutics has signed a collaboration and license agreement with Danish pharma producer Novo Nordisk....
EraCal Therapeutics AG’s €235 Million Licensing Agreement To Novo Nordisk
GlycoEra’s Incresing Its Series A Financing Round
Vischer advised GlycoEra AG on the deal. GlycoEra AG has closed CHF 45m (USD 49m) Series A financing round, co-led by re-nowned US and European life...
LASCCO SA and Abionic SA’s License Agreement With Fapon
VISCHER advised LASCCO SA on all legal issues related to the license agreement. LASCCO SA, a biomedical-technology company, and Abionic SA, a nanotechnology company, both based...
Nouscom’s €67.5 Million Oversuscribed Series C Financing Round
Walder Wyss advised the investors while VISCHER acted as legal advisor to Nouscom in the transaction. Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized...
LimmaTech Biologics AG’s $37 Million Series A Financing Round
VISCHER acted as legal advisor to LimmaTech Biologics in the transaction. LimmaTech Biologics AG closed a USD 37m (CHF 33m) Series A financing round co-led by Adjuvant...
Afinum’s Investment in Hofstetter PCB AG
VISCHER acted as legal counsel to Afinum on this transaction. Afinum invests in Hofstetter PCB AG (Hofstetter), the leading European provider of printed circuit boards plating...
Battery Ventures’ Acquisition of Avrios International AG
VISCHER advised Battery Ventures in the transaction as Swiss counsel alongside White & Case. US private equity investor Battery Ventures acquired Swiss-based SaaS startup Avrios International...
Rigeto Unternehmerkapital’s Acquisition of Prevention-Center
VISCHER advised Rigeto on all legal aspects of the cross-border transaction. A group of investors advised by Munich-based Rigeto Unternehmerkapital GmbH has acquired prevention-center as an add-on...
Bachem’s CHF 108.1 Million Accelerated Bookbuilding Process
VISCHER AG advises Bachem Holding on the offering. Bachem Holding AG (SIX: BANB) has successfully raised CHF 108.1 million through the placement of 1’250’000 new registered...
Medartis’ CHF 18 Million Acquisition of Additional Stake in KeriMedical
VISCHER advised Medartis on the deal. Medartis (SIX: MED), a Basel-based orthopedic company specializing in head and extremity surgery, recently signed an agreement with the private...
Genfit’s Acquisition of Versantis
VISCHER AG advised Versantis with Mark Fitzpatrick as CEO, Vincent Forster as CSO and Meriam Kabbaj as COO. Goodwin advised the sellers. Linklaters and Niederer Kraft...
e-hoi AG’s Acquisition of Cruise Center AG
VISCHER advised e-hoi AG on the deal. Cruise Center AG, a Swiss company that has been selling cruises for over twenty years, was acquired by the...